BIOFRONTERA AG NA O.N./ DE0006046113 /
| 2024-04-26 8:23:17 AM | Chg. -0.036 | Volume | Bid2:06:42 PM | Ask2:06:42 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.302EUR | -10.65% | 338 Turnover: 102.076 |
0.304Bid Size: 3,760 | 0.358Ask Size: 3,400 | 18.6 mill.EUR | 0.00% | 0.48 |
Assets
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .6000 | .3000 | .3000 | .2000 | .3000 | ||||||
| Intangible Assets | 1.7000 | 1.4000 | 1.3000 | 4.3000 | 3.8000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 2.3000 | 1.8000 | 1.5000 | 4.6000 | 4.1000 | ||||||
| Inventories | 0.0000 | .1000 | .2000 | .5000 | .9000 | ||||||
| Accounts Receivable | .1000 | 0.0000 | 0.0000 | 0.0000 | .3000 | ||||||
| Cash and Cash Equivalents | .2000 | 1.4000 | .7000 | .6000 | 3.4000 | ||||||
| Current Assets | 1.5000 | 1.6000 | 1.1000 | 1.1000 | 5 | ||||||
| Total Assets | 3.8000 | 3.4000 | 2.6000 | 5.7000 | 9 | ||||||
Liabilities
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.9000 | .6000 | .5000 | .7000 | .7000 | ||||||
| Long-term debt | 20.7000 | 11.3000 | 12.7000 | 10.6000 | 11.2000 | ||||||
| Liabilities to Banks | 21.4000 | 12.6000 | 12.7000 | 16.9000 | 11.6000 | ||||||
| Provisions | .5000 | .5000 | 2.2000 | .5000 | .7000 | ||||||
| Liabilities | 23.9000 | 13.7000 | 15.5000 | 18.2000 | 14.2000 | ||||||
| Share Capital | 3.3000 | 7.6000 | 10 | 11.2000 | 16.1000 | ||||||
| Total Equity | -20.1000 | -10.4000 | -12.9000 | -12.5000 | -4.1000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 3.8000 | 3.4000 | 2.6000 | 5.7000 | 9 | ||||||
Income Statement
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | .4000 | .3000 | .4000 | .5000 | 3.4000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -8.5000 | -5.4000 | -6.1000 | -4.4000 | -3.6000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -15.1000 | -3.3000 | -7.7000 | -4.6000 | -4.1000 | ||||||
| Income Taxes | 0.0000 | .1000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -15.1000 | -3.4000 | -7.7000 | -4.6000 | -4.1000 | ||||||
Per Share
Cash Flow
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -12.2000 | -3.7000 | -5.6000 | -4.7000 | -5.2000 | ||||||
| Cash Flow from Investing Activities | 3.5000 | .4000 | 0.0000 | -.3000 | -.1000 | ||||||
| Cash Flow from Financing | 4 | 4.5000 | 4.9000 | 4.8000 | 8.1000 | ||||||
| Decrease / Increase in Cash | -4.7000 | 1.3000 | -.7000 | -.1000 | 2.8000 | ||||||
| Employees | 28 | 23 | 20 | 27 | 34 | ||||||
